Search

Author/Creator Logothetis, Christopher J

1. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. Issue 2 (February 2015)

Authors:
Ryan, Charles J; Smith, Matthew R; Fizazi, Karim; Saad, Fred; Mulders, Peter F A; Sternberg, Cora N; Miller, Kurt; Logothetis, Christopher J; Shore, Neal D; Small, Eric J; Carles, Joan; Flaig, Thomas W; Taplin, Mary-Ellen; Higano, Celestia S; de Souza, Paul; de Bono, Johann S; Griffin, Thomas W; ...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 2(2015:Feb.)
Page Start:
152
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. Issue 2 (February 2015)

Authors:
Ryan, Charles J; Smith, Matthew R; Fizazi, Karim; Saad, Fred; Mulders, Peter F A; Sternberg, Cora N; Miller, Kurt; Logothetis, Christopher J; Shore, Neal D; Small, Eric J; Carles, Joan; Flaig, Thomas W; Taplin, Mary-Ellen; Higano, Celestia S; de Souza, Paul; de Bono, Johann S; Griffin, Thomas W; ...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 2(2015:Feb.)
Page Start:
152
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial. Issue 10 (October 2019)

Authors:
Corn, Paul G; Heath, Elisabeth I; Zurita, Amado; Ramesh, Naveen; Xiao, Lianchun; Sei, Emi; Li-Ning-Tapia, Elsa; Tu, Shi-Ming; Subudhi, Sumit K; Wang, Jennifer; Wang, Xuemei; Efstathiou, Eleni; Thompson, Timothy C; Troncoso, Patricia; Navin, Nicholas; Logothetis, Christopher J; Aparicio, Ana M
Journal:
Lancet oncology
Issue:
Volume 20:Issue 10(2019)
Page Start:
1432
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor). Issue 3 (22nd March 2023)

Authors:
Siddiqui, Bilal A; Chapin, Brian F; Jindal, Sonali; Duan, Fei; Basu, Sreyashi; Yadav, Shalini S; Gu, Ai-Di; Espejo, Alexsandra B; Kinder, Michelle; Pettaway, Curtis A; Ward, John F; Tidwell, Rebecca S S; Troncoso, Patricia; Corn, Paul G; Logothetis, Christopher J; Knoblauch, Roland; Hutnick, Nata...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 3(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Mitochondrial DNA copy number in peripheral blood leukocytes is associated with biochemical recurrence in prostate cancer patients in African Americans. (13th August 2019)

Authors:
Xu, Junfeng; Chang, Wen-Shin; Tsai, Chia-Wen; Bau, Da-Tian; Davis, John W; Thompson, Timothy C; Logothetis, Christopher J; Gu, Jian
Journal:
Carcinogenesis
Issue:
Volume 41:Number 3(2020)
Page Start:
267
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗